Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

NCT00556452 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Myelodysplastic Syndrome

Interventions

DRUG: Clofarabine/Busulfan x 4
PROCEDURE: Peripheral blood stem cell transplant
RADIATION: Total Lymphoid Irradiation

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]